Kinetic studies of the metabolism of rapidly exchangeable apolipoproteins may leave investigators and readers with exchangeable results

Arterioscler Thromb Vasc Biol. 2008 Oct;28(10):1685-6. doi: 10.1161/ATVBAHA.108.174185.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Apolipoprotein C-III / blood
  • Apolipoproteins / blood*
  • Apolipoproteins A / blood
  • Apolipoproteins B / blood
  • Atorvastatin
  • Cholesterol / blood
  • Down-Regulation
  • Dyslipidemias / blood
  • Dyslipidemias / drug therapy*
  • Fenofibrate / therapeutic use*
  • Heptanoic Acids / therapeutic use
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hypolipidemic Agents / therapeutic use*
  • Kinetics
  • Lipoproteins, VLDL / blood
  • Male
  • Metabolic Syndrome / blood
  • Metabolic Syndrome / drug therapy*
  • Pyrroles / therapeutic use
  • Research Design
  • Treatment Outcome
  • Triglycerides / blood

Substances

  • Apolipoprotein C-III
  • Apolipoproteins
  • Apolipoproteins A
  • Apolipoproteins B
  • Heptanoic Acids
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypolipidemic Agents
  • Lipoproteins, VLDL
  • Pyrroles
  • Triglycerides
  • Cholesterol
  • Atorvastatin
  • Fenofibrate